May 29, 2013 | Digital Pathology, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Pathologist Mark Rubin, M.D., is named to direct this early effort to adapt diagnostic and gene sequencing technologies to support personalized medicine
Following several years of experience with whole genome sequencing of tumors, two premier medical institutions announced their intent to move to the next step and establish an institute to support precision medicine. A prominent pathologist was named to head up this new institute.
Weill Cornell Medical College and New York-Presbyterian Hospital established a new, cutting-edge translational medicine research facility. It is called the Precision Medicine Institute and will use patients’ unique genetic profiles to develop individualized approaches for treating prostate cancer. (more…)
May 14, 2009 | Laboratory News, Laboratory Pathology
It may be that personalized medicine is becoming one of those All-American icons, like apple pie and mom. That’s because personalized medicine, as a concept and goal for the American healthcare system, seems to have universal support. If true, this is a positive long-term development for clinical laboratories and pathology groups.
Take the new president, for example. Barack Obama has long contended that personalized medicine must be at the heart of health care reform. “The issue of getting the right treatment to the right person goes with his [Obama’s] whole emphasis on health reform,” said Mark McClellan, who headed the FDA and Medicare under the Bush Administration. McClellan was speaking about President Obama during an interview with MSNBC. “If we’re thinking about reforming the healthcare system, we should be thinking about what medicine will be like down the road when healthcare reform is fully implemented,” observed McClellan during his MSNBC interview.
(more…)
May 11, 2009 | Laboratory News, Laboratory Pathology
Nation’s largest public health district wants to promote personalized medicine
Here’s an unusual development in genetic testing that shows clinical laboratory managers how fast the lab testing marketplace is changing. Two-hospital Palomar Pomerado Health (PPH), California’s largest public health district, recently partnered with 23andMe to introduce a personalized medicine service in North San Diego County.
PPH now sells 23andMe genetic test kits for $399 at express care centers in two grocery stores and an outpatient center. The test kit, Time magazine’s 2008 pick for Invention of the Year, comes with a 30-minute education session by a nurse practitioner.
(more…)
